Classical Least Squares for Quantitative Analysis of Pharmaceutical Solid Dosage Forms: Part 2—prediction Across a Changing Sample Matrix

Robert W. Bondi,Benoît Igne,Zhenqi Shi,Carl A. Anderson,James K. Drennen
DOI: https://doi.org/10.1255/nirn.1315
2012-01-01
NIR news
Abstract:P art 1 of this series demonstrated that caution must be exercised in experimental design selection when using Classical Least Squares (CLS) for pharmaceutical applications. An improper experimental design may produce a C matrix that is non-invertible during estimation of Ŝ, rendering CLS inappropriate as an approach for calibration. However, the authors demonstrated how improper experimental designs can be altered to an invertible form by calculating the chemical rank (number of degrees of freedom) of the C matrix using singular value decomposition (SVD). It was also discussed that CLS is generally not applicable for quantitative analysis due to violation of key assumptions of Beer’s Law. The second part of this series will demonstrate how extensions of CLS, specifically prediction augmented CLS (PACLS), can be used for quantitative determination of the active pharmaceutical ingredient (API) in a six-component compact system using near infrared (NIR) spectroscopy. A brief description of PACLS will be provided in subsequent sections; for a full description of the PACLS algorithm, the reader is directed to the publication by Haaland and Melgaard.
What problem does this paper attempt to address?